Aureomycin in the Treatment of Infectious Mononucleosis

CONFLICTING reports on the effectiveness of aureomycin in the treatment of infectious mononucleosis have appeared in the past year. Lyons and Hard1 studied 43 cases, — 25 controls and 18 treated patients. They shortened the average days of hospitalization from thirty-nine days to twenty-six days and the average length of the disease from forty-four days to thirty-two days; the duration of fever and liver involvement were strikingly less. Symptoms cleared in forty-eight hours. Other workers have had less favorable results. Seifert and his co-workers2 treated 47 patients by giving aureomycin or a placebo to patients at home and estimating results . . .